[1]
Saffarieh, E., Nassiri, S. and Mirmohammadkhani, M. 2022. Predicting value of HE4 and CA125 markers for optimal cytoreductive surgery in ovarian cancer patients. European Journal of Translational Myology. 32, 3 (Aug. 2022). DOI:https://doi.org/10.4081/ejtm.2022.10671.